We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
1726
People Inc
PPLI
$2.86B
-74,964
Closed -$3.1M
IART icon
1727
Integra LifeSciences
IART
$1.3B
-69,989
Closed -$2.67M
IBP icon
1728
Installed Building Products
IBP
$6.56B
-14,664
Closed -$1.83M
ICE icon
1729
Intercontinental Exchange
ICE
$90.5B
-51,034
Closed -$5.62M
ICLN icon
1730
iShares Global Clean Energy ETF
ICLN
$2.09B
$0 ﹤0.01%
23
IDCC icon
1731
InterDigital
IDCC
$8.84B
-21,438
Closed -$1.72M
IGMS
1732
DELISTED
IGM Biosciences
IGMS
-453,898
Closed -$3.79M
BRSL
1733
Brightstar Lottery PLC
BRSL
$2.21B
-19,280
Closed -$585K
IIPR icon
1734
Innovative Industrial Properties
IIPR
$1.56B
-6,555
Closed -$496K
IJR icon
1735
iShares Core S&P Small-Cap ETF
IJR
$111B
-9,000
Closed -$849K
IMCR icon
1736
Immunocore
IMCR
$1.9B
-72,159
Closed -$3.75M
IMKTA icon
1737
Ingles Markets
IMKTA
$1.61B
-10,929
Closed -$823K
IMTX icon
1738
Immatics
IMTX
$1.22B
-121,499
Closed -$1.41M
INCY icon
1739
Incyte
INCY
$25.9B
-119,392
Closed -$6.9M
INDI icon
1740
indie Semiconductor
INDI
$877M
-17,530
Closed -$110K
INSE icon
1741
Inspired Entertainment
INSE
$160M
-18,619
Closed -$223K
INSG icon
1742
Inseego
INSG
$72.1M
-2,387
Closed -$10K
INSM icon
1743
Insmed
INSM
$27.5B
-33,165
Closed -$837K
INTC icon
1744
Intel
INTC
$476B
-104,714
Closed -$4.25M
INTU icon
1745
Intuit
INTU
$100B
-7,725
Closed -$3.95M
INVA icon
1746
Innoviva
INVA
$1.52B
-68,923
Closed -$895K
INVH icon
1747
Invitation Homes
INVH
$17.9B
-63,624
Closed -$2.02M
IOVA icon
1748
Iovance Biotherapeutics
IOVA
$3.76B
-98,663
Closed -$449K
IQV icon
1749
IQVIA
IQV
$42.8B
-26,560
Closed -$5.23M
IRM icon
1750
Iron Mountain
IRM
$36.3B
-277,132
Closed -$16.5M

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.